756 related articles for article (PubMed ID: 15023377)
21. Magnetic resonance imaging (MRI) of articular cartilage in knee osteoarthritis (OA): morphological assessment.
Eckstein F; Cicuttini F; Raynauld JP; Waterton JC; Peterfy C
Osteoarthritis Cartilage; 2006; 14 Suppl A():A46-75. PubMed ID: 16713720
[TBL] [Abstract][Full Text] [Related]
22. Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study.
Bingham CO; Buckland-Wright JC; Garnero P; Cohen SB; Dougados M; Adami S; Clauw DJ; Spector TD; Pelletier JP; Raynauld JP; Strand V; Simon LS; Meyer JM; Cline GA; Beary JF
Arthritis Rheum; 2006 Nov; 54(11):3494-507. PubMed ID: 17075851
[TBL] [Abstract][Full Text] [Related]
23. Diacerein for osteoarthritis.
Fidelix TS; Soares BG; Trevisani VF
Cochrane Database Syst Rev; 2006 Jan; (1):CD005117. PubMed ID: 16437519
[TBL] [Abstract][Full Text] [Related]
24. Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis and reflections about related clinically relevant outcomes: expert consensus statement.
Reginster JY; Reiter-Niesert S; Bruyère O; Berenbaum F; Brandi ML; Branco J; Devogelaer JP; Herrero-Beaumont G; Kanis J; Maggi S; Maheu E; Richette P; Rizzoli R; Cooper C
Osteoarthritis Cartilage; 2015 Dec; 23(12):2086-2093. PubMed ID: 26187570
[TBL] [Abstract][Full Text] [Related]
25. The longterm outcome of osteoarthritis: rates and predictors of joint space narrowing in symptomatic patients with knee osteoarthritis.
Wolfe F; Lane NE
J Rheumatol; 2002 Jan; 29(1):139-46. PubMed ID: 11824950
[TBL] [Abstract][Full Text] [Related]
26. Compositional MRI techniques for evaluation of cartilage degeneration in osteoarthritis.
Guermazi A; Alizai H; Crema MD; Trattnig S; Regatte RR; Roemer FW
Osteoarthritis Cartilage; 2015 Oct; 23(10):1639-53. PubMed ID: 26050864
[TBL] [Abstract][Full Text] [Related]
27. Subgroup analyses of the effectiveness of oral glucosamine for knee and hip osteoarthritis: a systematic review and individual patient data meta-analysis from the OA trial bank.
Runhaar J; Rozendaal RM; van Middelkoop M; Bijlsma HJW; Doherty M; Dziedzic KS; Lohmander LS; McAlindon T; Zhang W; Bierma Zeinstra S
Ann Rheum Dis; 2017 Nov; 76(11):1862-1869. PubMed ID: 28754801
[TBL] [Abstract][Full Text] [Related]
28. Is loss in femorotibial cartilage thickness related to severity of contra-lateral radiographic knee osteoarthritis?--longitudinal data from the Osteoarthritis Initiative.
Cotofana S; Benichou O; Hitzl W; Wirth W; Eckstein F
Osteoarthritis Cartilage; 2014 Dec; 22(12):2059-66. PubMed ID: 25262648
[TBL] [Abstract][Full Text] [Related]
29. Risk factors associated with the loss of cartilage volume on weight-bearing areas in knee osteoarthritis patients assessed by quantitative magnetic resonance imaging: a longitudinal study.
Pelletier JP; Raynauld JP; Berthiaume MJ; Abram F; Choquette D; Haraoui B; Beary JF; Cline GA; Meyer JM; Martel-Pelletier J
Arthritis Res Ther; 2007; 9(4):R74. PubMed ID: 17672891
[TBL] [Abstract][Full Text] [Related]
30. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines.
Zhang W; Moskowitz RW; Nuki G; Abramson S; Altman RD; Arden N; Bierma-Zeinstra S; Brandt KD; Croft P; Doherty M; Dougados M; Hochberg M; Hunter DJ; Kwoh K; Lohmander LS; Tugwell P
Osteoarthritis Cartilage; 2008 Feb; 16(2):137-62. PubMed ID: 18279766
[TBL] [Abstract][Full Text] [Related]
31. Quantitative measurement of cartilage morphology in osteoarthritis: current knowledge and future directions.
Wirth W; Ladel C; Maschek S; Wisser A; Eckstein F; Roemer F
Skeletal Radiol; 2023 Nov; 52(11):2107-2122. PubMed ID: 36380243
[TBL] [Abstract][Full Text] [Related]
32. A low cartilage formation and repair endotype predicts radiographic progression of symptomatic knee osteoarthritis.
Luo Y; Samuels J; Krasnokutsky S; Byrjalsen I; Kraus VB; He Y; Karsdal MA; Abramson SB; Attur M; Bay-Jensen AC
J Orthop Traumatol; 2021 Mar; 22(1):10. PubMed ID: 33687578
[TBL] [Abstract][Full Text] [Related]
33. Disease-modifying osteoarthritis drugs: in vitro and in vivo data on the development of DMOADs under investigation.
Davies PS; Graham SM; MacFarlane RJ; Leonidou A; Mantalaris A; Tsiridis E
Expert Opin Investig Drugs; 2013 Apr; 22(4):423-41. PubMed ID: 23409708
[TBL] [Abstract][Full Text] [Related]
34. Long-Term Safety and Efficacy of Subcutaneous Tanezumab Versus Nonsteroidal Antiinflammatory Drugs for Hip or Knee Osteoarthritis: A Randomized Trial.
Hochberg MC; Carrino JA; Schnitzer TJ; Guermazi A; Walsh DA; White A; Nakajo S; Fountaine RJ; Hickman A; Pixton G; Viktrup L; Brown MT; West CR; Verburg KM
Arthritis Rheumatol; 2021 Jul; 73(7):1167-1177. PubMed ID: 33538113
[TBL] [Abstract][Full Text] [Related]
35. Plain radiography as an outcome measure in clinical trials involving patients with knee osteoarthritis.
Mazzuca SA; Brandt KD
Rheum Dis Clin North Am; 1999 May; 25(2):467-80, ix. PubMed ID: 10356429
[TBL] [Abstract][Full Text] [Related]
36. Glucosamine and chondroitin sulfate as therapeutic agents for knee and hip osteoarthritis.
Bruyere O; Reginster JY
Drugs Aging; 2007; 24(7):573-80. PubMed ID: 17658908
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the Chondromodulating Effect of Diacerein in OA of the Hip.
Dougados M; Nguyen M; Berdah L; Maziéres B; Vignon E; Lequesne M;
Arthritis Rheum; 2001 Nov; 44(11):2539-47. PubMed ID: 11710710
[TBL] [Abstract][Full Text] [Related]
38. Disease modifying osteoarthritis drugs: facing development challenges and choosing molecular targets.
Le Graverand-Gastineau MP
Curr Drug Targets; 2010 May; 11(5):528-35. PubMed ID: 20199396
[TBL] [Abstract][Full Text] [Related]
39. A protocol for a multicentre, randomised, double-blind, placebo-controlled trial to compare the effect of annual infusions of zoledronic acid to placebo on knee structural change and knee pain over 24 months in knee osteoarthritis patients - ZAP2.
Aitken D; Laslett LL; Cai G; Hill C; March L; Wluka AE; Wang Y; Blizzard L; Cicuttini F; Jones G
BMC Musculoskelet Disord; 2018 Jul; 19(1):217. PubMed ID: 30021646
[TBL] [Abstract][Full Text] [Related]
40. A family history of knee joint replacement increases the progression of knee radiographic osteoarthritis and medial tibial cartilage volume loss over 10 years.
Khan HI; Aitken D; Chou L; McBride A; Ding C; Blizzard L; Pelletier JP; Pelletier JM; Cicuttini F; Jones G
Osteoarthritis Cartilage; 2015 Feb; 23(2):203-9. PubMed ID: 25464166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
